GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » R1 RCM Inc (NAS:RCM) » Definitions » EPS (Diluted)

R1 RCM (R1 RCM) EPS (Diluted) : $0.01 (TTM As of Dec. 2023)


View and export this data going back to 2010. Start your Free Trial

What is R1 RCM EPS (Diluted)?

R1 RCM's Earnings per Share (Diluted) for the three months ended in Dec. 2023 was $0.01. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $0.01.

R1 RCM's EPS (Basic) for the three months ended in Dec. 2023 was $0.01. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was $0.01.

R1 RCM's EPS without NRI for the three months ended in Dec. 2023 was $0.04. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was $0.18.

During the past 12 months, R1 RCM's average EPS without NRIGrowth Rate was -25.00% per year. During the past 3 years, the average EPS without NRIGrowth Rate was -18.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, R1 RCM's highest 3-Year average EPS without NRI Growth Rate was 129.10% per year. The lowest was -64.40% per year. And the median was 2.00% per year.


R1 RCM EPS (Diluted) Historical Data

The historical data trend for R1 RCM's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

R1 RCM EPS (Diluted) Chart

R1 RCM Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EPS (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.08 0.32 -1.90 -0.18 0.01

R1 RCM Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.09 - - - 0.01

Competitive Comparison of R1 RCM's EPS (Diluted)

For the Health Information Services subindustry, R1 RCM's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


R1 RCM's PE Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, R1 RCM's PE Ratio distribution charts can be found below:

* The bar in red indicates where R1 RCM's PE Ratio falls into.



R1 RCM EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

R1 RCM's Diluted EPS for the fiscal year that ended in Dec. 2023 is calculated as

Diluted EPS (A: Dec. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(3.3-0)/454.094
=0.01

R1 RCM's Diluted EPS for the quarter that ended in Dec. 2023 is calculated as

Diluted EPS (Q: Dec. 2023 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(1.4-0)/451.865
=0.00

EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


R1 RCM  (NAS:RCM) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


R1 RCM EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of R1 RCM's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


R1 RCM (R1 RCM) Business Description

Traded in Other Exchanges
Address
434 West Ascension Way, 6th Floor, Murray, UT, USA, 84123
R1 RCM Inc is a provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers. Its services help healthcare providers generate sustainable improvements in their operating margins and cash flows while also enhancing patient, physician, and staff satisfaction for the customers, Its service offering consists of end-to-end RCM services for health systems, hospitals, and physician groups that provide comprehensive revenue cycle infrastructure to providers, including all revenue cycle personnel, technology solutions, and process workflow. The majority of the revenue comes from the operating fees received.
Executives
Dominic Nakis director 433 W ASCENSION WAY, SUITE 200, MURRAY UT 84123
Henneman John B Iii director 311 C ENTERPRISE DRIVE, PLAINSBORO NJ 08536
Evans Richard B. Jr. officer: Principal Accounting Officer C/O ACCRETIVE HEALTH, INC., 401 N. MICHIGAN AVENUE, SUITE 2700, CHICAGO IL 60611
John M. Sparby officer: See Remarks C/O R1 RCM INC., 401 N. MICHIGAN AVENUE, SUITE 2700, CHICAGO IL 60611
Lee Rivas officer: President C/O R1 RCM INC., 434 W. ASCENSION WAY, 6TH FLOOR, MURRAY UT 84123
Kyle Hicok officer: Chief Commercial Officer 434 W. ASCENSION WAY, 6TH FLOOR, MURRAY UT 84123
Jennifer D. Williams officer: Chief Financial Officer 434 W. ASCENSION WAY, 6TH FLOOR, MURRAY UT 84123
Janie Wade director C/O R1 RCM INC., 434 W. ASCENSION WAY, 6TH FLOOR, MURRAY UT 84123
Tcp-asc Achi Series Lllp director, 10 percent owner 65 E 55TH ST 27TH FLOOR, TOWERBROOK CAPITAL PARTNERS L.P., NEW YORK NY 10022
Joseph Gerard Flanagan director, officer: Chief Executive Officer C/O NORTEL NETWORKS CORPORATION, 195 THE WEST MALL, TORONTO A6 M9C 5K1
Brian K. Dean director R1 RCM INC., 434 W. ASCENSION WAY, 6TH FLOOR, MURRAY UT 84123
Gary Steven Long officer: See Remarks 7050 BRIXTON PLACE, SUWANEE GA 30024
Michael C. Feiner director 1166 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK NY 10036
Matthew S. Holt director C/O NEW MOUNTAIN CAPITAL, LLC, 787 SEVENTH AVENUE, 49TH FLOOR, NEW YORK NY 10019
Bradford Kyle Armbrester director 311 ARSENAL STREET, WATERTOWN MA 02472

R1 RCM (R1 RCM) Headlines